有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-Piperidin-4-yl-5-propan-2-ylsulfanyl-1,3,4-oxadiazole | —— | C10H17N3OS |
|
—— | 2-Methylsulfanyl-5-piperidin-1-ium-4-yl-1,3,4-oxadiazole | —— | C8H14N3OS+ |
|
—— | 2-[(4-Chlorophenyl)methylsulfanyl]-5-piperidin-1-ium-4-yl-1,3,4-oxadiazole | —— | C14H17ClN3OS+ |
|
—— | 2-Benzylsulfanyl-5-piperidin-1-ium-4-yl-1,3,4-oxadiazole | —— | C14H18N3OS+ |
|
—— | 2-[(2-Methylphenyl)methylsulfanyl]-5-piperidin-4-yl-1,3,4-oxadiazole | —— | C15H19N3OS |
|
—— | 3-[5-[(4-Methylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]propylazanium | —— | C13H18N3OS+ |
|
—— | (2R)-2-[2-(4-chlorophenyl)sulfanylethyl]piperidine | —— | C13H18ClNS |
|
—— | (2S)-2-(2-phenylsulfanylethyl)piperidine | —— | C13H19NS |
|
—— | 2-[(4-Methylphenyl)methylsulfanyl]-5-piperidin-4-yl-1,3,4-oxadiazole | —— | C15H19N3OS |
|
—— | 2-[(2-Chlorophenyl)methylsulfanyl]-5-piperidin-1-ium-4-yl-1,3,4-oxadiazole | —— | C14H17ClN3OS+ |
|
—— | (2R)-2-(2-phenylsulfanylethyl)piperidin-1-ium | —— | C13H20NS+ |
|
—— | N-(1-cyano-4-methylcyclohexyl)-2-{[4-cyclopropyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-methylacetamide | —— | C20H25N5OS2 |
|
—— | 2-[(3-Methylphenyl)methylsulfanyl]-5-piperidin-1-ium-4-yl-1,3,4-oxadiazole | —— | C15H20N3OS+ |
|
—— | (2S)-2-[2-(4-chlorophenyl)sulfanylethyl]piperidine | —— | C13H18ClNS |
|
—— | 2-[(4-Methylphenyl)methylsulfanyl]-5-piperidin-1-ium-4-yl-1,3,4-oxadiazole | —— | C15H20N3OS+ |
|
—— | 3-(5-Propylsulfanyl-1,3,4-oxadiazol-2-yl)propan-1-amine | —— | C8H15N3OS |
|
—— | 3-(5-Propylsulfanyl-1,3,4-oxadiazol-2-yl)propylazanium | —— | C8H16N3OS+ |
|
—— | 3-[5-[(2-Fluorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]propylazanium | —— | C12H15FN3OS+ |
|
—— | (2R)-2-[2-(4-chlorophenyl)sulfanylethyl]piperidin-1-ium | —— | C13H19ClNS+ |
|
—— | 2-[(2-Fluorophenyl)methylsulfanyl]-5-piperidin-1-ium-4-yl-1,3,4-oxadiazole | —— | C14H17FN3OS+ |
|
—— | c-[5-(4-Fluoro-benzylsulfanyl)-[1,3,4]oxadiazol-2-yl]-methylamine | —— | C10H10FN3OS |
|
—— | (2S)-N-benzyl-2-[(4-cyclopropyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-N-ethylpropanamide | —— | C21H24N4OS2 |
|
—— | (1S,2S)-1-(5-ethylsulfanyl-1,3,4-oxadiazol-2-yl)-2-methylbutan-1-amine | —— | C9H17N3OS |
|
—— | 3-(5-Benzylsulfanyl-1,3,4-oxadiazol-2-yl)propan-1-amine | —— | C12H15N3OS |
|
—— | [5-[(2-Chlorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]methanamine | —— | C10H10ClN3OS |
|
—— | 3-[5-[(2-Methylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]propan-1-amine | —— | C13H17N3OS |
|
—— | [5-[(2-Methylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]methanamine | —— | C11H13N3OS |
|
—— | (1S,2R)-2-methyl-1-(5-propylsulfanyl-1,3,4-oxadiazol-2-yl)butan-1-amine | —— | C10H19N3OS |
|
—— | [(1S)-2-methyl-1-(5-propylsulfanyl-1,3,4-oxadiazol-2-yl)propyl]azanium | —— | C9H18N3OS+ |
|
—— | [5-[(4-Methylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]methylazanium | —— | C11H14N3OS+ |
|
—— | [5-[(3-Methylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]methylazanium | —— | C11H14N3OS+ |
|
—— | (1S)-3-methyl-1-(5-propylsulfanyl-1,3,4-oxadiazol-2-yl)butan-1-amine | —— | C10H19N3OS |
|
—— | 2-propylsulfanyl-5-[(2S)-pyrrolidin-2-yl]-1,3,4-oxadiazole | —— | C9H15N3OS |
|
—— | 2-propylsulfanyl-5-[(2S)-pyrrolidin-1-ium-2-yl]-1,3,4-oxadiazole | —— | C9H16N3OS+ |
|
—— | [(1S,2S)-2-methyl-1-[5-[(3-methylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]butyl]azanium | —— | C15H22N3OS+ |
|
—— | [(1S,2S)-1-(5-ethylsulfanyl-1,3,4-oxadiazol-2-yl)-2-methylbutyl]azanium | —— | C9H18N3OS+ |
|
—— | [(1S,2R)-2-methyl-1-(5-propylsulfanyl-1,3,4-oxadiazol-2-yl)butyl]azanium | —— | C10H20N3OS+ |
|
—— | (5-Propylsulfanyl-1,3,4-oxadiazol-2-yl)methylazanium | —— | C6H12N3OS+ |
|
—— | (1S)-2-methyl-1-(5-propylsulfanyl-1,3,4-oxadiazol-2-yl)propan-1-amine | —— | C9H17N3OS |
|
—— | [(1S,2S)-1-[5-[(4-chlorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]azanium | —— | C14H19ClN3OS+ |
|
—— | 5-[(4,5-Dimethyl-1,2,4-triazol-3-yl)sulfanyl]-2-methylpyrazolo[1,5-a]quinazoline | —— | C15H14N6S |
|
—— | 1-[(2S)-2-(5-ethylfuran-2-yl)azepan-1-yl]-2-phenylsulfanylethanone | —— | C20H25NO2S |
|
—— | 1-[(2R)-2-(5-ethylfuran-2-yl)azepan-1-yl]-2-phenylsulfanylethanone | —— | C20H25NO2S |
|
—— | 1-[2-(4-chlorophenyl)sulfanylethyl]-3-[(2S)-1-(3,5-dimethyl-1,2-oxazol-4-yl)propan-2-yl]urea | —— | C17H22ClN3O2S |
|
—— | 3-[(2R)-1-(3,5-dimethyl-1,2-oxazol-4-yl)propan-2-yl]-1-methyl-1-[(4-methylsulfanylphenyl)methyl]urea | —— | C18H25N3O2S |
|
—— | 1-[(2R)-1-(3,5-dimethyl-1,2-oxazol-4-yl)propan-2-yl]-3-(3-phenylsulfanylpropyl)urea | —— | C18H25N3O2S |
|
—— | 3-[(2S)-1-(3,5-dimethyl-1,2-oxazol-4-yl)propan-2-yl]-1-methyl-1-[(4-methylsulfanylphenyl)methyl]urea | —— | C18H25N3O2S |
|
—— | 1-[2-(4-chlorophenyl)sulfanylethyl]-3-[(2R)-1-(3,5-dimethyl-1,2-oxazol-4-yl)propan-2-yl]urea | —— | C17H22ClN3O2S |
|
—— | 1-[(2S)-1-(3,5-dimethyl-1,2-oxazol-4-yl)propan-2-yl]-3-(3-phenylsulfanylpropyl)urea | —— | C18H25N3O2S |
|
—— | N-[(2S)-2-methyl-3-morpholin-4-ylpropyl]-2-phenylsulfanylacetamide | —— | C16H24N2O2S |
|